WeVote
Log In

Bill

Bill

S 4203

Requires certain standards be established for contracts between pharmacy benefits managers and health benefits plans.

2026-2027 Regular Session Introduced by Raj Mukherji

New Jersey bill S 4203 would require minimum standards for PBM-health plan contracts to boost transparency, protections, and accountability in drug benefits.

0
WeVote Research Nonpartisan
Bill Summary · S 4203

Summary of Bill S 4203 (New Jersey, Session 222)

Purpose and intent

S 4203 seeks to establish minimum standards governing contracts between pharmacy benefits managers (PBMs) and health benefits plans in New Jersey. The overarching aim is to increase transparency, accountability, and consumer protections in the administration of prescription drug benefits. The bill is sponsored in part by Raj Mukherji as a co-sponsor.

Key provisions and changes

  • Standards for PBM–Health Plan Contracts: The bill requires that contracts between PBMs and health benefits plans meet specified criteria. While the exact language of the standards is not provided here, typical elements in such bills include disclosures, performance expectations, conflict-of-interest provisions, and consumer protection safeguards.

  • Transparency Requirements: Provisions likely mandate more transparent reporting related to drug pricing, rebates, and administrative fees. This may include requirements for plan sponsors and PBMs to disclose negotiated rebate amounts, discount structures, and any "spread pricing" practices.

  • Network and Formulary Arrangements: The bill may address how formularies, preferred networks, and contract terms are managed to ensure fair access to medications for enrollees and to curb anti-competitive or exclusive arrangements.

  • Consumer Protections: Provisions could include protections against unreasonable cost shifts to enrollees, requirements for timely member communications about formulary changes, and clear information about coverage and out-of-pocket costs.

  • Audit and Compliance: The bill may authorize or require audits, examinations, or enforcement mechanisms to ensure contracts comply with the established standards. It could specify penalties for noncompliance or mechanisms to address violations.

  • Effective Date/Phased Implementation: The bill typically provides an effective date and any phased implementation schedule, allowing plans and PBMs time to comply with the new standards.

Who would be affected

  • Pharmacy Benefits Managers (PBMs): Direct impact through new contract standards and potential compliance obligations, disclosures, and audit requirements.
  • Health Benefits Plans/Insurers: Plans that contract with PBMs would need to ensure their agreements meet the established standards.
  • Employers and Employees/Enrollees: Indirect impact through potential changes in PBM practices that affect drug access, pricing, and transparency.
  • Pharmacy Providers and Pharmacies: May experience shifts in formulary management, reimbursement terms, or network participation as contract standards influence payer–PBM dynamics.

Procedural and timeline considerations

  • Legislative Process: As a sponsored bill, it would follow New Jersey legislative procedures, including committee review, potential amendments, floor votes, and eventual consideration by the full Legislature, with a possible path to the governor for signature.
  • Effective Date: The statute would specify an effective date upon enactment or a staged implementation period to allow parties to adapt to the new standards.
  • Regulatory Alignment: If enacted, state health department or insurance regulator guidance and rulemaking may accompany or flesh out the contract standards to ensure enforceability and uniform interpretation.

This summary captures the core aims and structural aspects likely encompassed by S 4203 based on its title and scope. For precise statutory language, timelines, and any amendments, please refer to the bill text and accompanying fiscal notes or committee analyses.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.